Off-Target Effects Predominate The Cellular Response To The "Septin Drug" Forchlorfenuron

被引：0
|
作者：
Heasley, L. R. [1 ]
McMurray, M. A. [1 ]
机构：
[1] Univ Colorado Denver Anschutz Med Campus, Mol Biol, Aurora, CO USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
1567
引用
收藏
页数：1
相关论文
共 50 条
  • [41] REPLY: Intriguing Off-Target Effects of Ezetimibe
    Tsujita, Kenichi
    Sugiyama, Seigo
    Shimomura, Hideki
    Yamanaga, Kenshi
    Kaikita, Koichi
    Hokimoto, Seiji
    Ogawa, Hisao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (24) : 2808 - 2809
  • [42] Characterizing off-target effects of genome editors
    Rao, Xichen
    Zhao, Huanan
    Shao, Chuyun
    Yi, Chengqi
    CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2023, 28
  • [43] A comparative metabolomic analysis of PPAR activators for evaluating drug on- and off-target effects
    Berger, Alvin
    Stevens, Dan
    Milburn, Michael
    FASEB JOURNAL, 2007, 21 (05): : A455 - A455
  • [44] Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation
    Brody, J. A.
    Sitlani, C. M.
    Ye, T.
    Bis, J. C.
    Davies, N. M.
    Floyd, J. S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [45] Combinatorial Anticancer Drug Screen Identifies Off-Target Effects of Epigenetic Chemical Probes
    Barghout, Samir H.
    Mann, Mandeep K.
    Aman, Ahmed
    Yu, Yifan
    Alteen, Matthew G.
    Schimmer, Aaron D.
    Schapira, Matthieu
    Arrowsmith, Cheryl H.
    Barsyte-Lovejoy, Dalia
    ACS CHEMICAL BIOLOGY, 2022, 17 (10) : 2801 - 2816
  • [46] Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation
    Brody, J. A.
    Sitlani, C. M.
    Ye, T.
    Bis, J. C.
    Davies, N. M.
    Floyd, J. S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [47] Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors
    Antolin, Albert A.
    Mestres, Jordi
    ONCOTARGET, 2014, 5 (10) : 3023 - 3028
  • [48] AMPK and Polycystic Kidney Disease Drug Development: An Interesting Off-Target Target
    Caplan, Michael J.
    FRONTIERS IN MEDICINE, 2022, 9
  • [49] Empowering drug off-target discovery with metabolic and structural analysis
    Sourav Chowdhury
    Daniel C. Zielinski
    Christopher Dalldorf
    Joao V. Rodrigues
    Bernhard O. Palsson
    Eugene I. Shakhnovich
    Nature Communications, 14
  • [50] Empowering drug off-target discovery with metabolic and structural analysis
    Chowdhury, Sourav
    Zielinski, Daniel C.
    Dalldorf, Christopher
    Rodrigues, Joao V.
    Palsson, Bernhard O.
    Shakhnovich, Eugene I.
    NATURE COMMUNICATIONS, 2023, 14 (01)
12345